CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
4.280
-0.420 (-8.94%)
At close: Jun 22, 2026, 4:00 PM EDT
4.200
-0.080 (-1.87%)
After-hours: Jun 22, 2026, 7:08 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $6.26 million as of June 22, 2026. Its market cap has increased by 13.39% in one year.
Market Cap
6.26M
Enterprise Value
3.54M
1-Year Change
13.39%
Ranking
Category
Stock Price
$4.28
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $6.26M, a decrease of -91.05%. That is a compound annual growth rate of -30.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 6.26M | 92.08% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 7.30M |
| Imunon | 7.25M |
| Ernexa Therapeutics | 7.23M |
| Psyence Biomedical | 7.22M |
| Immuron | 6.87M |
| Aptorum Group | 6.78M |
| Silo Pharma | 6.64M |
| Acurx Pharmaceuticals | 6.59M |